RCH logo

Microbiology

RCH Antimicrobial Sensitivity Data 2012

  • Gram positive blood culture isolates RCH 2012

    Organism Penicillin Flucloxacillin Cefotaxime Erythromycin Vancomycin Teicoplanin Clindamycin Linezolid
    Group A streptococcus (n=19) 19/19
    (100%)    		   2/2
    (100%)    		 17/19
    (89%)    		 19/19
    (100%)    		   16/19
    (84%)    		 2/2
    (100%)
    Streptococcus pneumonia (n=14) 5/5
    (100%)    		   6/6
    (100%)    		 14/14
    (100%)    		 14/14
    (100%)    		   14/14
    (100%)    		 1/1
    (100%)
    Viridans streptococci (n=63) 31/63
    (49%)    		   50/61
    (82%)    		 19/63
    (30%)    		 63/63
    (100%)    		   50/63
    (79%)    		 3/3
    (100%)
    Enterococcus spp. (n=36) 26/36
    (82%)    		     9/36
    (25%)    		 33/36
    (92%)    		 36/36
    (100%)    		 1/34
    (3%)     		34/34
    (100%)
    Staphylococcus  aureus (n=67) 5/67
    (8%)    		 66/67
    (100%)    		   60/67
    (90%)    		 62/62
    (100%)    		 62/63
    (98%)    		 60/67
    (90%)    		 54/54
    (100%)
    Coagulase Negative Staphylococci (n=434) 32/434
    (8%)    		 112/434
    (26%)    		   195/434
    (45%)    		 433/433
    (100%)    		 420/431
    (97%)    		 291/434
    (67%)    		 410/411
    (100%)

     Key: Green: >80% susceptible

     Gram negative blood culture isolates RCH 2012

    Organism Ciprofloxacin Tobramycin Amikacin Cefotaxime Tazocin Timentin Meropenem
    E. coli (n=82) 69/81
    (85%)    		 73/81
    (90%)    		 78/81
    (96%)    		   57/81
    (70%)    		 49/81
    (61%)    		 81/81
    (100%)
    Enterobacter spp. (n=50) 29/32
    (91%)    		 32/32
    (100%)     		32/32
    (100%)    		   28/31
    (90%)    		 26/32
    (81%)    		 32/32
    (100%)
    Klebsiella spp. (n=43) 40/43
    (93%)     		43/43
    (100%)    		 43/43
    (100%)    		   39/42
    (93%)    		 36/43
    (84%)    		 43/43
    (100%)
    Pseudomonas  aeruginosa (n=19) 18/19
    (95%)     		19/19
    (100%)    		 19/19
    (100%)     		  17/19
    (90%)    		 11/19
    (58%)    		 19/19
     (100%)


    Organism Ampicillin Augmentin Cephalexin Trimethoprim Cotrimoxazole Gentamicin
    E. coli (n=82) 25/81
    (30%)    		 51/82
    (62%)    		 11/73
    (15%)    		 37/72
    (51%)    		 62/81
    (77%)    		 78/82
    (95%)
    Enterobacter spp. (n=50) 0/48
    (0%)    		 0/48
    (0%)    		 0/41
    (0%)    		 16/44
    (36%)    		 16/48
    (33%)    		 35/48
    (73%)
    Klebsiella spp. (n=43) 0/43
    (0%)    		 41/43
    (95%)    		 24/36
    (67%)    		 25/39
    (64%)    		 27/43
    (63%)    		 42/43
    (98%)
    Pseudomonas  aeruginosa (n=19)  

    		 

    		   

    		 

    		18/19
    (95%)

       Key: Green: >80% susceptible